173 related articles for article (PubMed ID: 21567923)
1. Lethal presentation of neurofibromatosis and Noonan syndrome.
Prada CE; Zarate YA; Hagenbuch S; Lovell A; Schorry EK; Hopkin RJ
Am J Med Genet A; 2011 Jun; 155A(6):1360-6. PubMed ID: 21567923
[TBL] [Abstract][Full Text] [Related]
2. Different mutations in the NF1 gene are associated with Neurofibromatosis-Noonan syndrome (NFNS).
Baralle D; Mattocks C; Kalidas K; Elmslie F; Whittaker J; Lees M; Ragge N; Patton MA; Winter RM; ffrench-Constant C
Am J Med Genet A; 2003 May; 119A(1):1-8. PubMed ID: 12707950
[TBL] [Abstract][Full Text] [Related]
3. Novel association of neurofibromatosis type 1-causing mutations in families with neurofibromatosis-Noonan syndrome.
Ekvall S; Sjörs K; Jonzon A; Vihinen M; Annerén G; Bondeson ML
Am J Med Genet A; 2014 Mar; 164A(3):579-87. PubMed ID: 24357598
[TBL] [Abstract][Full Text] [Related]
4. Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome.
Thiel C; Wilken M; Zenker M; Sticht H; Fahsold R; Gusek-Schneider GC; Rauch A
Am J Med Genet A; 2009 Jun; 149A(6):1263-7. PubMed ID: 19449407
[TBL] [Abstract][Full Text] [Related]
5. A variable combination of features of Noonan syndrome and neurofibromatosis type I are caused by mutations in the NF1 gene.
Hüffmeier U; Zenker M; Hoyer J; Fahsold R; Rauch A
Am J Med Genet A; 2006 Dec; 140(24):2749-56. PubMed ID: 17103458
[TBL] [Abstract][Full Text] [Related]
6. Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?
Yapijakis C; Pachis N; Natsis S; Voumvourakis C
In Vivo; 2016; 30(3):315-20. PubMed ID: 27107091
[TBL] [Abstract][Full Text] [Related]
7. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway.
Reig I; Boixeda P; Fleta B; Morenoc C; Gámez L; Truchuelo M
Dermatol Online J; 2011 Apr; 17(4):4. PubMed ID: 21549079
[TBL] [Abstract][Full Text] [Related]
8. Noonan Syndrome Case Report: PTPN11 and Other Potential Genetic Factors Contributing to Lethal Hypertrophic Right Ventricular Cardiomyopathy.
Daoud E; Zwick D
Pediatr Dev Pathol; 2019; 22(4):386-390. PubMed ID: 30665336
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis-Noonan Syndrome: A Possible Paradigm of the Combination of Genetic and Epigenetic Factors.
Yapijakis C; Pachis N; Voumvourakis C
Adv Exp Med Biol; 2017; 987():151-159. PubMed ID: 28971455
[TBL] [Abstract][Full Text] [Related]
10. PTPN11 gene analysis in 74 Brazilian patients with Noonan syndrome or Noonan-like phenotype.
Bertola DR; Pereira AC; Albano LM; De Oliveira PS; Kim CA; Krieger JE
Genet Test; 2006; 10(3):186-91. PubMed ID: 17020470
[TBL] [Abstract][Full Text] [Related]
11. Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.
Bertola DR; Pereira AC; Passetti F; de Oliveira PS; Messiaen L; Gelb BD; Kim CA; Krieger JE
Am J Med Genet A; 2005 Jul; 136(3):242-5. PubMed ID: 15948193
[TBL] [Abstract][Full Text] [Related]
12. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
[TBL] [Abstract][Full Text] [Related]
13. NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome.
De Luca A; Bottillo I; Sarkozy A; Carta C; Neri C; Bellacchio E; Schirinzi A; Conti E; Zampino G; Battaglia A; Majore S; Rinaldi MM; Carella M; Marino B; Pizzuti A; Digilio MC; Tartaglia M; Dallapiccola B
Am J Hum Genet; 2005 Dec; 77(6):1092-101. PubMed ID: 16380919
[TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype.
Stevenson DA; Viskochil DH; Rope AF; Carey JC
Clin Genet; 2006 Mar; 69(3):246-53. PubMed ID: 16542390
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of 40 patients with Noonan syndrome.
Ferrero GB; Baldassarre G; Delmonaco AG; Biamino E; Banaudi E; Carta C; Rossi C; Silengo MC
Eur J Med Genet; 2008; 51(6):566-72. PubMed ID: 18678287
[TBL] [Abstract][Full Text] [Related]
16. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
[TBL] [Abstract][Full Text] [Related]
17. PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?
Faienza MF; Giordani L; Ferraris M; Bona G; Cavallo L
Pediatr Cardiol; 2009 Oct; 30(7):1012-5. PubMed ID: 19582499
[TBL] [Abstract][Full Text] [Related]
18. Juvenile xanthogranuloma in Noonan syndrome.
Ali MM; Gilliam AE; Ruben BS; Tidyman WE; Rauen KA
Am J Med Genet A; 2021 Oct; 185(10):3048-3052. PubMed ID: 34032360
[TBL] [Abstract][Full Text] [Related]
19. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
[TBL] [Abstract][Full Text] [Related]
20. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
